GLYCOMIMETICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.271 USD | -1.09% |
|
+0.37% | -88.52% |
| 09/05 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 07/05 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYCOMIMETICS, INC. | Bio Therapeutic Drugs | -1.09% | +0.37% | -88.52% | -85.89% | -97.71% | 1.75Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GLYC Stock
- Charts GlycoMimetics, Inc.
- Comparison Chart
